Drug
Tigecycline (Tygacil)
Tigecycline (Tygacil) is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
not_yet_recruiting125%
completed375%
Recent Activity
0 active trials
Showing 4 of 4
completed
Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital
NCT06750744
not_yet_recruiting
Comparing Tigecycline Vs. Colistimethate in CNS Infections
NCT06702943
completed
Tygacil Drug Use Investigation
NCT01789905
completed
Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
NCT00683332
Clinical Trials (4)
Showing 4 of 4 trials
NCT06750744
Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital
NCT06702943
Comparing Tigecycline Vs. Colistimethate in CNS Infections
NCT01789905
Tygacil Drug Use Investigation
NCT00683332
Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4